Takeda Pharmaceutical (TAK) Goodwill & Intangibles (2018 - 2026)
Takeda Pharmaceutical has reported Goodwill & Intangibles over the past 9 years, most recently at $58.8 billion for Q1 2026.
- For Q1 2026, Goodwill & Intangibles changed 0.24% year-over-year to $58.8 billion; the TTM value through Mar 2026 reached $58.8 billion, changed 0.24%, while the annual FY2026 figure was $61.3 billion, 4.27% up from the prior year.
- Goodwill & Intangibles was $58.8 billion for Q1 2026 at Takeda Pharmaceutical, roughly flat from $58.7 billion in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $70.8 billion in Q1 2022 and bottomed at $58.7 billion in Q1 2025.
- The 5-year median for Goodwill & Intangibles is $65.4 billion (2024), against an average of $64.4 billion.
- Year-over-year, Goodwill & Intangibles dropped 10.17% in 2025 and then grew 0.24% in 2026.
- Over 5 years, Goodwill & Intangibles stood at $70.8 billion in 2022, then fell by 3.23% to $68.5 billion in 2023, then fell by 4.59% to $65.4 billion in 2024, then fell by 10.17% to $58.7 billion in 2025, then grew by 0.24% to $58.8 billion in 2026.
- The last three reported values for Goodwill & Intangibles were $58.8 billion (Q1 2026), $58.7 billion (Q1 2025), and $65.4 billion (Q1 2024) per Business Quant data.